Dr. Budder Siddiqui, MD

Dr. Siddiqui practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Dr. Siddiqui's NPI, 1366670051, was assigned on July 1, 2009. Dr. Siddiqui holds Georgia license 81576.

Dr. Siddiqui's primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Dr. Siddiqui's primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. Dr. Siddiqui is also affiliated with Northside Hospital Atlanta. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology. Dmand AI also links Dr. Siddiqui to 2 more hospitals, 9 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Siddiqui practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Siddiqui's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Siddiqui's licenses on file in 2 states: Georgia and New York.

CMS data shows 1,237 Medicare services from Dr. Siddiqui across 16 procedure codes in 2024, for 477 Medicare patients. Medicare paid $88,190 for them.

CMS counts 477 Medicare patients who saw Dr. Siddiqui in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Siddiqui's median patient age at 71, with 52% women.

In 2024, Dr. Siddiqui wrote 2,285 Medicare Part D claims for 527 patients. 85% of them were for generic drugs. CMS names the drug for 2,031 of them, across 42 drugs with 11 or more claims each, at $997,773 in total drug cost. In 2023, CMS named 1,238 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Siddiqui for performance year 2024, reported as part of a group. Dr. Siddiqui accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Siddiqui as offering telehealth.

Dmand AI links 13 papers to Dr. Siddiqui, published from 2019 to 2023. 2022 was the busiest year, with 5. The most frequent topics are Kidney Failure, Chronic, Renal Dialysis and Psoriasis. Dr. Siddiqui has published most often in Am J Med Sci. Dr. Siddiqui's most frequent co-authors are Mufaddal F. Kheda, MD, Sarah Yen Tran, MD and Sandeep Anand Padala, MD.

CMS Open Payments shows 45 general payments to Dr. Siddiqui from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 98% of the total. ViiV Healthcare Company paid the most, $226.